许昆林在江苏自贸试验区南京片区调研时强调

Group 1 - The provincial government emphasizes the importance of implementing the recently approved open innovation development plan for the biopharmaceutical industry in Jiangsu, aiming to enhance the province's global competitiveness in this sector [1][2][3] - The focus is on integrating technological and industrial innovation, leveraging policy advantages to boost the entire biopharmaceutical value chain, including research, manufacturing, distribution, and usage [1][2] - The government encourages collaboration between enterprises, universities, and clinical institutions to drive new drug development and technology transfer, aiming for significant breakthroughs in the industry [2][3] Group 2 - Jiangsu's biopharmaceutical industry is identified as a key area for growth, with the government aiming to create a competitive and attractive innovation ecosystem [2][3] - The implementation of the open authorization plan is expected to facilitate cross-border flows of talent, capital, and data, enhancing the province's ability to attract global resources [2] - The government calls for coordinated efforts among departments and localities to ensure the effective execution of the plan, aiming to generate replicable and scalable success stories in the biopharmaceutical sector [3]